Skip to main content

Table 2 Informed dissent exceptions, overall exceptions and population achievement rates (median %) for 2010–2013

From: Incentivised chronic disease management and the inverse equity hypothesis: findings from a longitudinal analysis of Scottish primary care practice-level data

 

ID

Overall exception reporting

Population achievement

 

2010–2011

2011–2012

2012–2013

2010–2011

2011–2012

2012–2013

2010–2011

2011–2012

2012–2013

Indicator

 BP 04 record of BPa

0.78

0.88

1.09

1.87

1.79

2.26

91.30

91.21

91.21

 BP 05 last BPa ≤ 150/90 mmHg

0.96

1.11

1.42

4.44

4.56

4.97

78.21

78.34

79.64

 COPD 08 influenza vaccine in the preceding 7 months

1.85

1.99

2.19

13.76

13.33

12.68

81.51

81.82

82.26

 COPD 10 record of forced expiratory volume in 1 sb

3.57

3.91

4.42

14.81

15.79

15.97

78.07

76.64

77.00

 COPD 13 review, including MRC (Medical Research Council) scoreb

3.42

3.70

4.23

12.11

12.50

12.15

82.10

81.53

81.93

 DM 02 record of body mass indexb

1.48

1.59

1.75

3.62

3.58

3.56

92.20

91.98

91.89

 DM 10 neuropathy testingb

2.10

2.27

2.52

6.58

6.56

6.81

86.65

86.72

86.10

 DM 13 micro-albuminuria testingb

2.24

2.47

2.56

5.67

5.53

5.78

87.23

87.12

86.32

 DM 17 last measured total cholesterol ≤ 5 mmol/Lb

2.24

2.40

2.63

10.71

10.75

11.83

75.38

74.51

74.18

 DM 18 influenza vaccine in preceding 7 months

2.16

2.17

2.42

16.02

15.41

14.80

78.26

78.66

78.49

 DM 21 retinal screeningb

1.65

1.73

1.92

9.80

9.53

9.62

85.30

85.49

85.71

 DM 22 record of estimated glomerular filtration rate or creatinineb

1.23

1.21

1.33

2.24

2.21

2.23

95.45

95.52

95.85

 STROKE 06 TIA or stroke with BPb ≤ 150/90 mmHg

0.56

0.66

0.71

4.55

4.88

4.76

85.71

85.62

86.11

 STROKE 07 TIA or stroke with a record of total cholesterolb

0.85

1.02

1.06

4.55

4.65

4.79

88.99

88.71

89.44

 STROKE 08 TIA or stroke with last measured total cholesterolb ≤ 5 mmol/L

1.12

1.39

1.49

12.68

13.24

13.43

70.59

70.49

70.77

 STROKE10 TIA or stroke with influenza vaccine in preceding 7 months

0.74

1.03

1.04

15.66

14.53

13.79

78.08

78.81

79.42

 EPILEP 08 ≥ 18 years old on drug treatment and seizure free for past 12 months

1.16

1.92

2.08

24.00

24.32

25.00

58.73

58.62

57.41

 EPILEP 06 ≥ 18 years old on drug treatment with a record of seizure frequencyb

0.00

0.00

0.00

4.00

4.94

5.00

91.30

90.57

91.09

 CHD 06 last BPb ≤ 150/90 mmHg

0.75

0.71

0.64

3.29

3.17

3.33

88.41

87.94

88.60

 CHD 08 last total cholesterolb ≤ 5 mmol/L

1.25

1.26

1.11

10.13

10.46

10.99

75.25

73.24

73.49

 CHD 12 influenza vaccine in preceding 7 months

0.99

0.95

0.92

12.90

12.13

11.60

82.40

82.82

82.90

 CKD 02 record of BPb in those with CKD

0.00

0.00

0.00

0.56

0.63

0.62

97.35

97.18

97.16

 CKD 03 last BPb ≤ 140/85 mmHg

0.00

0.00

0.00

6.46

6.31

6.27

70.97

71.59

72.33

 CKD 06 record of urine albumin to creatinine ratio (or protein to creatinine ratio)b

0.00

0.00

0.20

3.91

3.85

3.76

83.07

83.02

83.08

 DEM 02 care has been reviewedb in those with dementia

0.00

0.00

0.00

5.56

5.17

6.25

75.68

76.77

78.33

 DEP 01 DM/CHD with depression screenb

0.43

0.51

0.40

3.64

3.64

3.95

87.45

86.75

86.62

 PP 01 new hypertensive medication (without CHD, diabetes, stroke and/or TIA)c with a cardiovascular risk assessment using approved tool

0.00

0.00

0.00

12.50

12.50

11.11

73.33

72.22

75.56

 PP 02 hypertensive medication; given lifestyle adviceb for physical activity, smoking, alcohol and healthy diet

0.00

0.00

0.00

6.67

4.76

3.39

79.55

80.49

82.86

 THYROI 02 hypothyroidism with thyroid function testsb

0.00

0.00

0.00

0.47

0.52

0.59

95.91

95.80

95.45

All indicators combined

0.76

0.88

0.96

7.04

7.02

6.92

83.51

83.41

83.63

  1. Data are presented as the median percentage. a in the previous 9 months; b in the previous 15 months; c in the past year.
  2. BP blood pressure, CHD coronary heart disease, CKD chronic kidney disease, COPD chronic obstructive pulmonary disease, DEM dementia, DEP depression, EPILIP epilepsy, DM diabetes mellitus, PP primary prevention of heart disease, THYROI thyroid disease, TIA transient ischaemic attack